Pharmaceutical preparations for genetic therapies to treat genetically driven disorders in the fields of neurology, gastroenterology, metabolism, immunology, dyslipidaemia, the musculoskeletal system, oncology, and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system, and kidney; Reagents, nucleic acids, and nucleotides for medical and veterinary purposes; all of the foregoing excluding pharmaceuticals for the treatment of xerostomia